Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,588.00
Bid: 2,590.00
Ask: 2,596.00
Change: 58.00 (2.29%)
Spread: 6.00 (0.232%)
Open: 2,586.00
High: 2,594.00
Low: 2,542.00
Prev. Close: 2,530.00
CCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Statement

30 Jan 2023 07:00

RNS Number : 1750O
Computacenter PLC
30 January 2023
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

FOR IMMEDIATE RELEASE

Computacenter plc

Pre-Close Trading Update - 30 January 2023

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on preliminary unaudited financial information, for the year ended 31 December 2022 ("the year").

Overview

Computacenter has finished the year with a record fourth quarter, which will result in an eighteenth consecutive year of underlying* adjusted diluted earnings per share growth, and a 2022 full-year result which is slightly ahead of the guidance given by the Group in its Q3 Trading Update. Whilst our performance in 2022 has been helped by a strong US dollar, and a small acquisition in the second half of the year, this assistance has been far outweighed by the headwinds faced by the business as the Covid-related benefits it experienced in 2020 and 2021 unwound, particularly impacting our Services margins.

Financial Performance

Total revenue, on a Gross Invoiced Income basis, grew by over 30 percent including the effects of acquisitions made in the middle of 2022, and by over 27 per cent in constant currency.

We saw strong demand in all countries from Technology Sourcing product sales which remained extremely buoyant to the end of the year. Our Services revenue performance was strong, whilst our Services margin performance was impacted by the unwinding of covid-related benefits during the year, and inflationary pressures which we expect to continue into 2023.

Financial Position

The Group's adjusted net funds, excluding IFRS16 lease liabilities, finished extremely strongly at around £244 million. At the half year we reported substantial increases in our inventory, primarily as a result of supply chain shortages within the industry. Whilst our inventory levels continued to increase through until the end of the third quarter, these shortages have since improved materially, and as a result there has been a substantial reversal of this inventory position as the industry, and particularly our customers, readjusted to more plentiful supply. We expect our levels of inventory to reduce further in 2023, towards historical normal levels, as this trend continues. December is the peak month in our annual cash cycle with net outflows expected to occur through to the end of March 2023 in line with our cash cycle.

Group Outlook

In line with our expectations, adjusted profit before tax was down in the first half of the year against H1 2021, by nearly 6 per cent. We are therefore pleased with the profit growth which we have subsequently achieved for the year as a whole, and the significant momentum that we will carry into 2023, including in our previous and in-year US acquisitions, which have continued to make good progress, both in terms of profit growth and cash generation.

Covid-19 factors have now washed through our results and will not impact comparative numbers moving forward.

Our Technology Sourcing product sales remain extremely buoyant, and we are confident of continued Services revenue growth. Services margins are broadly in line with pre-covid levels, although inflationary pressures will make it challenging to maintain this in the short-term.

As we announced at the half year and in our Q3 Trading Update, Computacenter has an ambitious investment programme within the business, particularly in systems, to enhance our competitive position and sustain our long-term performance. Despite the uncertain macro-economic outlook within a number of our core countries, and our substantial investment programme, we expect 2023 to be another year of progress.

Looking further ahead, we are encouraged by our customers continued investment in technology, and we are as bullish as we have ever been about our target market and competitive positioning.

We look forward to publishing our final results for the year ended 31 December 2022 on Monday 20 March 2023.

 

Enquiries:

Computacenter plc

 

Mike Norris, Chief Executive

01707 631601

Tony Conophy, Finance Director

01707 631515

Tulchan Communications

 

James Macey White / Matt Low

020 7353 4200

 

* As described on pages 72 to 73 of our 2021 Annual Report and Accounts, several one-off tax items were processed during the second half 2021 that substantially reduced the tax charge, and therefore the adjusted ETR, for the year as a whole. These one-off items are excluded from our internal underlying adjusted diluted earnings per share measure which is used for measuring our progress against LTIP performance conditions. Had the one-off items not impacted during 2021, the underlying adjusted1 diluted EPS for 2021 would have been 160.9 pence per share.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLMPTMTTTBTJ
Date   Source Headline
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.